BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2020 9:59:40 AM | Browse: 393 | Download: 596
 |
Received |
|
2020-05-18 21:17 |
|
Peer-Review Started |
|
2020-05-18 21:18 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-06-07 23:11 |
|
Revised |
|
2020-06-24 23:07 |
|
Second Decision |
|
2020-09-04 06:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-09-05 01:43 |
|
Articles in Press |
|
2020-09-05 01:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-09-12 20:30 |
|
Typeset the Manuscript |
|
2020-10-20 01:44 |
|
Publish the Manuscript Online |
|
2020-10-26 09:59 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Rheumatology |
| Manuscript Type |
Case Report |
| Article Title |
Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ping-Yang Han, Hui-Hui Chi and Yu-Tong Su |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81801600 |
| Shanghai Sailing Program |
18YF1414500 |
|
| Corresponding Author |
Yu-Tong Su, MD, PhD, Doctor, Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No.197 Ruijin Second Road, Shanghai 200025, China. suyt2015@163.com |
| Key Words |
Multicentric Castleman disease; Lymphocytic interstitial pneumonia; Skin involvement; Interlukin-6; Tocilizumab; Case report |
| Core Tip |
We reported a case of idiopathic multicentric Castleman disease (iMCD) with pulmonary parenchyma and skin involvement as the primary clinical manifestations. The patient had presented to several tertiary hospitals for more than 3 years before he was finally diagnosed. iMCD is a rare systemic lymphoproliferative disease, and delays in diagnosis are common and remain a concern. Clinicians need to improve their understandings of iMCD. Combination therapy with anti-interlukin (IL)-6 monoclonal antibodies and glucocorticoids is an effective frontline treatment regimen, especially for those with an elevated level of serological IL-6. |
| Publish Date |
2020-10-26 09:59 |
| Citation |
Han PY, Chi HH, Su YT. Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report. World J Clin Cases 2020; 8(20): 4922-4929 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i20/4922.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i20.4922 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
